Google
Google
×
Any time
  • Any time
  • Past hour
  • Past 24 hours
  • Past week
  • Past month
  • Past year
Verbatim
Official website vaccine against coronavirus Sputnik V. The first registered vaccine against COVID-19 Sputnik V. About Vaccine · Sputnik moment · Media · About Us
Sputnik V is the world's first registered vaccine based on a well-studied human adenoviral vector-based platform. It currently ranks among top-10 candidate ... Clinical Trials · Adenoviral vaccines · List of studies on adenovirus ...
Nov 11, 2020 · Developers of the Sputnik V vaccine announce phase III results, two days after Pfizer and BioNTech released the first compelling evidence that ...
Gam-COVID-Vac trade-named Sputnik V (V for vaccine), is a COVID-19 vaccine candidate developed by the Gamaleya Research Institute of Epidemiology and ... Technology · Development and ... · Preliminary clinical ... · Scientific assessment
Nov 11, 2020 · Institute cites interim review based on 20 cases in trial, but provides little more information on Sputnik V vaccine.
Oct 1, 2020 · On Aug 11, Russia announced the launch of Sputnik V, its home brewed adenovirus-based vaccine candidate against COVID-19 and by Sept 4 ...
The Russian COVID-19 vaccine Sputnik V (Gam-COVID-Vac) is an adenoviral- based vaccine against the SARS-CoV-2 coronavirus. Sputnik V uses a weakened ...
Nov 11, 2020 · Moscow (CNN) Russia's sovereign wealth fund said on Wednesday that an early analysis of data from its Sputnik V coronavirus vaccine ...
2 hours ago · Russia's Sputnik V coronavirus vaccine is 95 percent effective according to a second interim analysis of clinical trial data, its developers said on ...
Nov 11, 2020 · MOSCOW (Reuters) - Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the ...